Tenzing Acquisition Corp.
Status: Closed Deal
U=S+W
W=S@11.5
| IPO Proceeds, $M | $63.25M |
|---|---|
| IPO Date | Aug 21, 2018 |
| CEO | Rahul Nayar |
| Left Lead | Maxim |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 18+3+2+1+1+3 |
| IPO Sector | General ▶ |
| IPO Geography | Asia |
| Target Company | Reviva Pharma |
| Deal Announced | Jul 21, 2020 |
| Deal Size, $M | $85.80M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Dec 8, 2020 |
| Amendment Vote | TBD |
| Closing Date | Dec 14, 2020 |
Formerly TZAC
RVPH
RVPHW
| Price | $0.60 |
|---|---|
| Last closing price | $0.60 |
| H/L, today | $0.59 / $0.62 |
| H/L, 52-week | $3.04 / $9.25 |
| Volume, today | 3,749,703 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.